Broderick Brian C Reduces Stake in Xylem Inc. (NYSE:XYL)

Broderick Brian C lessened its stake in shares of Xylem Inc. (NYSE:XYLFree Report) by 0.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 71,350 shares of the industrial products company’s stock after selling 200 shares during the quarter. Xylem comprises 1.9% of Broderick Brian C’s portfolio, making the stock its 23rd largest holding. Broderick Brian C’s holdings in Xylem were worth $9,634,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. EverSource Wealth Advisors LLC grew its stake in Xylem by 68.8% during the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after acquiring an additional 77 shares in the last quarter. Bangor Savings Bank grew its position in shares of Xylem by 56.7% during the 3rd quarter. Bangor Savings Bank now owns 235 shares of the industrial products company’s stock valued at $32,000 after purchasing an additional 85 shares in the last quarter. Mark Sheptoff Financial Planning LLC bought a new position in shares of Xylem in the second quarter worth $33,000. Blue Trust Inc. raised its position in shares of Xylem by 1,185.7% in the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after buying an additional 249 shares in the last quarter. Finally, Assetmark Inc. boosted its stake in Xylem by 3,887.5% during the third quarter. Assetmark Inc. now owns 319 shares of the industrial products company’s stock valued at $43,000 after buying an additional 311 shares during the period. 87.96% of the stock is currently owned by institutional investors.

Xylem Stock Performance

NYSE XYL opened at $121.63 on Friday. The firm has a market cap of $29.55 billion, a price-to-earnings ratio of 35.56, a PEG ratio of 2.28 and a beta of 1.05. The company has a 50-day simple moving average of $130.86 and a two-hundred day simple moving average of $134.76. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 12-month low of $99.90 and a 12-month high of $146.08.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The business had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.17 billion. During the same period last year, the company earned $0.99 EPS. Xylem’s revenue for the quarter was up .2% compared to the same quarter last year. On average, equities analysts forecast that Xylem Inc. will post 4.23 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on XYL shares. Royal Bank of Canada decreased their target price on Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Stifel Nicolaus upped their price objective on shares of Xylem from $170.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, July 31st. Robert W. Baird dropped their target price on shares of Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. UBS Group initiated coverage on shares of Xylem in a report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price target on the stock. Finally, TD Cowen dropped their price objective on shares of Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a report on Wednesday, November 6th. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, Xylem has a consensus rating of “Moderate Buy” and an average target price of $147.17.

Read Our Latest Stock Report on Xylem

Xylem Company Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Recommended Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.